TNF-alpha induced PMN apoptosis in whole human blood: protective effect of SSR180575, a potent and selective peripheral benzodiazepine ligand

Biochemical and Biophysical Research Communications
N Leducq-AletFrançoise Bono

Abstract

The peripheral benzodiazepine receptor (PBR) has been shown to play a key role in the regulation of the mitochondrial process leading to apoptosis. Despite much controversy in the literature on this subject, PBR synthetic ligands (and specifically agonists such as Ro5-4864 and SSR180575) are described as presenting potent anti-apoptotic effect against oxidative stress, TNFalpha- and tamoxifen-induced apoptosis when the PBR ligand is administrated at a low dose, close to the affinity range of the ligand to its receptor. Such anti-apoptotic activity has already been correlated with a protective effect of PBR ligands against ischemia-reperfusion induced tissue dysfunction. Previously, we had shown that SSR180575 is a specific and high affinity PBR ligand of potential interest in pathological cardiovascular, renal and neurodegenerative indications. Beyond its expression in steroid-producing tissues, heart, liver and kidney, the PBR is also known to be highly expressed in blood cells. In this work, we demonstrate by flow cytometry experiments, that SSR180575, at low concentrations, is able to protect polymorphonuclear leukocytes (PMNs) against TNFalpha-induced apoptosis in whole blood. Thus, in a new context, SSR180575 again shows p...Continue Reading

References

Oct 20, 1977·Nature·C BraestrupR F Squires
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M W McEneryS H Snyder
Dec 1, 1985·Journal of Neurochemistry·P J SyapinE P Noble
Nov 24, 1999·Biochemical and Biophysical Research Communications·F BonoJ M Herbert
Oct 3, 2001·Journal of Neurovirology·J R LokensgardP K Peterson
Aug 21, 2003·The Journal of Pharmacology and Experimental Therapeutics·Nathalie LeducqJean-Marc Herbert
Oct 11, 2003·Biochemical and Biophysical Research Communications·V VinJ M Herbert
Feb 16, 2005·Biochemical Pharmacology·Gregory HansJean-Michel Rigo
Oct 26, 2005·Cell Death and Differentiation·N ZamzamiG Kroemer
Apr 5, 2007·Nature Protocols·Carlo Riccardi, Ildo Nicoletti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis